CVKD CADRENAL THERAPEUTICS INC
FollowCOM (common), issuer CIK 1937993
16 managers (17 13F filers) reported a position in CVKD shares at 2026-06-30, 112,464 shares in all. 6 filers opened a position and 6 filers sold out during the quarter.
- Managers
- 16
- 13F filers
- 17
- New
- 6
- Added
- 4
- Reduced
- 1
- Sold out
- 6
- Shares held by filers
- 112,464
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.
- Baggett Benjamin Matthew Wall
300,000 shares, 7.3% in a 13G as of 2026-11-16,0002163771-26-000002
Accepted , ingested
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q2 2026
Filers in the available 13F reports with a share position at 2026-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
Events
Baggett Benjamin Matthew Wall reported 300,000 CVKD shares, 7.3% of the class, as of 2026-11-16, in a 13G filed 2026-11-17. 0002163771-26-000002
Accepted , ingested